Oncology Central

How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?


The treatment of pediatric rhabdomyosarcoma (RMS) of the pelvis has been changing in recent years. Local treatment after chemotherapy is delayed or even avoided completely without effecting overall survival. Imaging is playing a growing role in individualized treatment planning in these patients. In cases of questionable recurrence or residual disease, fusion biopsies may allow a safe and reliable bioptic examination.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.